.Exelixis is losing hope on its tissue variable (TF)- targeting antibody-drug conjugate after ending...
.3 weeks after Roche's Genentech unit bowed out an SHP2 inhibitor contract, Relay Therapy has actual...
.Stoke Therapeutics' Dravet syndrome drug has actually been without a predisposed hold, removing the...
.Intense Biotech Colleague Publisher Gabrielle Masson offered the 2024 class of Tough 15 winners on ...
.Novo Nordisk has axed its once-monthly twin GLP-1/ GIP receptor agonist, finishing (PDF) advancemen...
.Merck & Co. has promptly recovered some of the expenses of its own Javelin Rehabs purchase, attr...
.After BioMarin performed a springtime clean of its pipe in April, the business has determined that ...
.Major Pharmas stay caught to the concept of molecular adhesive degraders. The latest company to see...
.A brand new worldwide life science credit history agency, nicknamed Symbiotic Capital, has actually...
.Bristol Myers Squibb is axing yet another big bet from the Caforio time, ending a package for Agenu...